Researchers recommend new standard of care for families with hereditary neuroblastoma linked to ALK mutation
Researchers at Children's Hospital of Philadelphia (CHOP) highlighted the success of anaplastic lymphoma kinase (ALK) inhibition therapy in treating hereditary neuroblastoma, a rare subset of a common childhood cancer. Researchers ...
May 6, 2025
0
18
